FIELD: medicine.
SUBSTANCE: group of inventions relates to medicine and concerns a cosmetic method for the treatment of sweating in humans, including the use of at least one Xn+ cation with n valence, at least one Ym- anion with m valence and at least one modulating agent, where the specified Xn+ cation is polyvalent inorganic and is selected from: (i) alkaline earth metal cations selected from calcium and magnesium, and (ii) transition metal cations selected from zinc, manganese, titanium, copper, zirconium and iron; the specified Ym- anion is selected from carbonate (CO32-), hydrocarbonate (HCO3-), phosphate (PO43-), polyphosphates such as diphosphate P2O74−, triphosphate P3O105−, phosphonate (PO33-), hydrophosphate (HPO42-), sulfate (SO42-), sulfonate (SO32-), hydrosulfate (HSO4-), hydrosulfonate (HSO3-) and silicate (SiO32-); and the specified modulating agent is selected from mono- or polycarboxylic acids, optionally hydroxylated, in free or saline form; ascorbic acid; polymers or copolymers of carboxylic acids in free or saline form, polymers or copolymers of amino carboxylic acids in free or saline form. The group of inventions also concerns a cosmetic composition for the treatment of sweating in humans.
EFFECT: group of inventions provides the treatment of sweating in humans.
21 cl, 27 ex
Authors
Dates
2021-08-24—Published
2018-10-09—Filed